SCHEMBL1675112

SCHEMBL1675112

CCNC(=O)c1ccc(-c2ccc3ncnc(N(C)C4CCCO4)c3c2)o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 6/20 0.44
CLK4 Q9HAZ1 7/20 0.40
CLK2 P49760 5/20 0.40
DYRK1B Q9Y463 5/20 0.40
DYRK1A Q13627 4/20 0.40
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
MAP4K4 O95819 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
PDPK1 O15530 2/20 0.35
CLK3 P49761 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1674991 0.88 CLK4 (0.47) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675212 0.82 CLK4 (0.54) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675188 0.81 CLK4 (0.46) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675111 0.80 CLK4 (0.57) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675187 0.79 CLK4 (0.39) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675291 0.77 CLK4 (0.50) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675221 0.75 CLK1 (0.49) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675100 0.73 CLK4 (0.55) CLK1CLK4CLK2DYRK1BALDH1A1
SCHEMBL1675232 0.71 CLK4 (0.66) CLK1CLK4CLK2DYRK1BDYRK1A
SCHEMBL1675287 0.69 CLK4 (0.79) CLK1CLK4CLK2DYRK1BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed